Director of the Institute of Toxicology at the University of Mainz, Senior Professor

Postdoctoral Fellow at the German Cancer Research Center and the Nuclear Research Center in Karlsruhe

Member of the Board of Directors of the Turkish Society of Medical Oncology

Chief Physician, Professor and Doctoral Supervisor of Three Gorges Hospital, Chongqing University

Director of the Medical Pathology Center, Clinical Research Center, Early Diagnosis and Treatment Center for Tumors and Translational Medicine Research Center

Director of the Middle Line (NUT) Cancer Specialty

Clinical Focus: Early diagnosis and standardized treatment of tumors, including the establishment of the first national NUT midline carcinoma specialty and the creation of an integrated diagnosis and treatment platform for this disease. Research Focus: Anti-tumor clinical drug development and translational research; research on tumor immune regulation mechanisms; research on the synergistic mechanism of tumor epigenetics and immunity. Currently Responsible Projects: Obtained 5 clinical approval documents for national 1.1 class new drugs; led the formulation of 1 national expert consensus and participated in the formulation of 1 consensus; won the first prize of the China Industry-University-Research Cooperation Innovation Award (individual), the first prize of the China Invention Association's Entrepreneurship and Innovation Award (1/6), the first prize of the Ministry of Education's Scientific and Technological Progress Award (6/16), and the second prize of the provincial and ministerial scientific and technological progress award (6/8); applied for over 20 national invention patents and software copyrights, with 5 authorized; published over 110 SCI papers, including over 50 as first or corresponding author; research results published in Nature, Advanced Science, Science Translational Medicine, JCI, J Hepatol, Circulation Research, Nature Communication, etc.; led 1 sub-project of the National Key Research and Development Program and 2 National Natural Science Foundation of China general projects. Main Academic Appointments: President of the Digital Healthcare Committee of the China Food and Drug Safety Enterprise Quality Promotion Association (FDSA), Vice Chairman of the Integrated Lung Cancer Prevention and Screening Committee of the China Anti-Cancer Association, Chairman of the NUT Midline Carcinoma Gene Diagnosis Working Group of the Gene Diagnosis Committee of the China Anti-Cancer Association, Vice President of the Overseas Chinese Association of Science and Technology and the Liaison Officer of Chongqing.

Chief Physician of the Department of Hematology, Henan Cancer Hospital
National Committee Member of the Hemostasis and Thrombosis Group of the Chinese Medical Association
National Committee Member of the Hematology Branch of the Chinese Geriatrics Society
Member of the International Society of Hemostasis and Thrombosis (ISTH)
Standing Committee Member of the Tumor Critical Care Professional Committee of the Henan Anti-Cancer Association
Vice Chairman of the Thromboembolism Branch of the Henan Microcirculation Society

Associate Professor of Eskişehir Osmangazi University, Faculty of Medicine, Department of Internal Medicine

 Associate Professor, Trakya University Faculty of Medicine, Department of Internal Medicine

Researcher, Adipose Stem Cell and Fat Metabolism Research Group, Guangdong Key Laboratory of Stem Cell and Regenerative Medicine
Research Group Leader, Key Laboratory of Regenerative Biology, Chinese Academy of Sciences

Director and Professor, Zhengzhou University, China

Recipient of the State Council Special Allowance, China
Academic Vice President, Medical School, Zhengzhou University
Chief Scientist, The First Affiliated Hospital of Zhengzhou University
Director, Biotherapy Center and Division of Bioimmunotherapy, The First Affiliated Hospital of Zhengzhou University
Member, European Society of Immunology (ESI); American Association for Cancer Research (AACR); American Association of Immunologists (AAI)
Council Member, Chinese Society of Immunology
Chair, Professional Committee on Biotherapy, Henan Anti-Cancer Association & Henan Society of Immunology
Executive Vice Chair, Cell Therapy Quality Management and Research Branch, China Quality Management Association for Pharmaceuticals
Vice Chair, Biotherapy Branch, Chinese Society of Research Hospitals
Standing Council Member, Committee on Tumor Immunotherapy, Chinese Anti-Cancer Association (CACA)
Committee Member, Immuno-Oncology Committee, Chinese Society of Clinical Oncology (CSCO)

Professor of Obstetrics, Gynecology, Endoscopic Surgery and Reproductive Medicine, Ain Shams University, Cairo, Egypt.

Consultant of Obstetrics, Gynecology and Endoscopic Surgery, Ahmadi Hospital, Kuwait Oil Company (KOC), Kuwait.

Visiting Professor in West Kazakhstan Medical University, Aktobe, Kazakhstan since 2018-2019.

Certified Publons Academy Mentor, Supervisor and Reviewer

Editorial Board Member of the BMC Series (BMC Women`s Health)

Editorial Board Member of the Gynecology, Obstetrics, Reproductive Medicine (GORM-Turkey).

Member of the European Society of Human Reproduction and Embryology (ESHRE)-E-13-00010.

Professor of Radiology and the Managing Director of the Nuclear Diagnostic Imaging Centre at Universiti Putra Malaysia (UPM)

Dr Akhter is working as Assistant Professor-I in School of Pharmaceutical and Population Health Informatics (SoPPHI), DIT University, Dehradun, India since 09 October 2017. He has graduated and Master in Pharmacy (Pharmaceutics) from Jamia Hamdard, New Delhi and completed doctoral program in 2016. He had qualified GATE Exam conducted by IIT, Kanpur, Govt of India, percentile score 97.04 in 2007. He had honoured with JRF by UGC Govt. of India, SRF by DST-SERB Govt of India. His work of interest is novel drug delivery system, nanomedicine, nanotechnology-based formulation design, engineering nanoparticles, their surface functionalization for various target diseases including cancer treatment, and development of animal model/xenograft model. He has published >65 research and review papers in high impact journal of repute, 05 book chapters, 07 patents published and 03 Granted, and peer reviewed >50 articles. His present cumulative impact factor is >150 and H-index is 21, Google citation is 1107, Publon-Web of Science citation (755). He has attended and presented many papers at national and international conferences/seminars/symposia. He is an editorial board member of Eur J Med and Oncology (JCR Clarivate IF-2.5). He has been awarded with the research excellence award for the consecutive years 2019, and 2020, and 2021, and 2022 in DIT University.

Dr. Georgios Alexiou is an Associate Professor of Neurosurgery at the University Hospital of Ioannina, Greece since 2017. He undertook his neurosurgical training at ‘’Agia Sofia’’ Children’s Hospital in Athens, Greece and at the University Hospital of Ioannina, Greece. After finishing his residency, he received the EANS Spine Fellowship award and worked as a Clinical Fellow in the Department of Neurosurgery in Leeds Teaching Hospital, UK. He then received the AANS International Travelling Fellowship in Pediatric Neurosurgery award at the Department of Pediatric Neurosurgery in Boston Children's Hospital, Harvard Medical School. Dr. Alexiou worked as a consultant at the Gamma Knife Center at the University Hospital La Timone in Marseille, France. He has a Master degree in Biotechnology and Public Health. His PhD thesis was on the differential diagnosis of glioma recurrence from radiation necrosis using SPECT and MRI and resulted in a clinical study that was funded by the Horizon 2020 program of the European Commission (5M Euro). Dr. Alexiou worked as a postdoctoral research fellow at MD Anderson Cancer Center in Houston Texas and is currently working also on basic research at the Neurosurgical Institute in Ioannina, Greece. He has authored more than 290 international publications in the field, one academic book, edited one book and he is in the editorial board of several International Journals. His primary research interests are intraoperative flow cytometry for brain tumor surgery, pediatric neurosurgery, advanced imaging and radiotherapy techniques for gliomas and on the discovery and validation of novel plant derived compounds for glioma treatment.

Dr. William Cho is a biomedical scientist at the Department of Clinical Oncology, Queen Elizabeth Hospital in Hong Kong. With a strong background in cancer biomarker discovery and translational research, Dr. Cho has published extensively in peer-reviewed journals. His research interests include genomics, proteomics, and liquid biopsy in oncology. He actively serves on editorial boards and is a frequent reviewer for international scientific journals.

Dr. Alfio Ferlito is Formerly Director of the Department of Surgical Sciences at the University of Udine School of Medicine from 2003 to 2009 and Professor and Chairman of the ENT Clinic at the same University from 1997 to 2013. He graduated in medicine at the University of Bologna in 1968. He completed his residency programme in Otolaryngology and subsequently in pathology. He worked at the ENT Department of Padua University from 1970 to 1997. Since 2009 he is the Coordinator of the International Head Neck Scientific Group.

Dr. Alfio Ferlito received many honors and awards during his career.  He served as editor, co-editor, assistant editor or reviewer for the 736 journals. He has collaborated in writing articles, editorials, commentaries, letters to the editor, special issues, book chapters and books with 665 international experts. He has edited a three-volume book entitled Cancer of the Larynx (CRC Press, Boca Raton, 1985) and three other books entitled Neoplasms of the Larynx (Churchill Livingstone, Edinburgh, 1993), etc. He is Editor of four issues of ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery. He has been author and co-author of 657 referred publications in 70 medical journals and 54 chapters in various books. He is a fellow or a member of the many societies. He collaborated as a member of the World Health Organization’s Committee on Histological Typing of Tumors of the Upper Respiratory Tract and Ear. He is also a member of the Laryngeal Cancer Association’s Committee on the Classification of Laryngeal Cancer. He was a consultant to Yale University. He was a consultant to Yale University. He has delivered prestigious lectures all over the world. In 2006 he gave the 2nd Morrison Lecture in San Francisco and the 19th Som Lecture in New York. He has divided his professional life between clinical practice, teaching and research.

Pedro Fonte is Assistant Professor at the Faculty of Sciences and Technology, University of Algarve, Portugal. He is also an integrated member at Center of Marine Sciences (CCMAR), University of Algarve, Portugal and collaborator researcher at the Institute for Bioengineering and Biosciences, Instituto Superior Técnico, University of Lisbon, Portugal. He graduated in Pharmaceutical Sciences in 2010 and obtained his PhD in Pharmaceutical Sciences – Nanotechnologies specialty at the Faculty of Pharmacy, University of Porto, Portugal in collaboration with the University of Copenhagen, Denmark, in 2016. He also obtained a Master of Business Administration (MBA) at the Faculty of Economics and Business Management, Lusíada University, Portugal in 2012. His area of scientific activity is on the development of new drug delivery systems by means of colloidal carriers, structural characterization of proteins entrapped into micro- and nanocarriers, lyophilization of biopharmaceuticals, targeted and controlled delivery of drugs across biological barriers, solid state characterization of pharmaceuticals and drying of pharmaceuticals and biopharmaceuticals. He is also conducting research in the regenerative medicine field, focusing in wound healing, tissue regeneration and cell therapy. In his activity he is enrolled in the up-scale of pharmaceutical products and is involved in entrepreneurship activities.

Professor at University of California, Los Angeles, United States.

Dr. Hu is a Professor and was previously the MS Program Advisor in the Division of Oral and Systemic Health Sciences at the UCLA School of Dentistry. He has managed the Oral Biology MS program since 2011. Dr. Hu is also a member of the UCLA Jonsson Comprehensive Cancer Center (JCCC) and currently serving as an editorial board member for multiple international journals. He recently edited the Cancer metabolomics: Methods and Applications for Springer Advances in Experimental Medicine and Biology book series.

Prof. Hannah Xiaoyan HUI obtained her B.Sc. (First Class Honours) in Biotechnology from Shanghai Jiao Tong University and completed her Ph.D. study in Shanghai Institute of Biological Sciences, Chinese Academy of Sciences (SIBS, CAS). She then pursued her postdoctoral training at Department of Medicine, the University of Hong Kong and was later took up her post as Research Assistant Professor at the same department. In 2021, she joined the School of Biomedical Sciences, the Chinese University of Hong Kong as Assistant Professor.

The research interest of Dr. Hui lies solely on Adipose Tissue – a highly plastic organ in our body. We are using genetically engineered mouse models, primary cells/tissues and human iPS-derived adipocytes as model systems. By adopting state-of-the-art, multidisciplinary approaches, the goal of our laboratory is to understand the molecular basis of adipose tissue remodelling and its physiological relevance in obesity and cardio-metabolic diseases. Ultimately we seek to develop biomedicine that can “re-educate” the adipose tissue.

Prof. Hui is the principal investigator of research grants including General Research fund (GRF), Health and Medical Research Fund (HMRF) and NSFC (Young Excellent Scientist). Her research work has been published in top-ranked journals including Cell Metab, J Clin Invest, EMBO rep, Diabetes, Brit J Pharmacol. She also receives awards such as National Science and Technology Progress Award (2020).

Full Professor of Advanced Medical and Surgical Technical Sciences, University of Catania, Italy

Consultant Neurologist & Chief, Clinical Neurophysiology Research Unit, Oasi Research Institute‑IRCCS (a WHO Collaborating Centre), Troina, Italy

Assistant Professor (Senior Academic Researcher), University of Catania

Visiting Clinical Research Fellow, Department of Neuroscience & Clinical Neurophysiology, Newcastle University, UK

Scientific Fellow selected by the European Federation of Neurological Societies (EFNS), 2013

International award for translational research in sleep medicine

Dr. John Spiliotis is a distinguished surgical oncologist affiliated with both the European Interbalkan Medical Center in Thessaloniki and Athens Medical Center in Athens, Greece. He has extensive clinical experience in oncology surgery and has contributed significantly to cancer treatment strategies, particularly in gastrointestinal and hepatobiliary cancers. Dr. Spiliotis is actively involved in academic research and has published widely in international medical journals.